Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Baltimore, Maryland

CNS trials open to children and teens in Baltimore, MD

9 CNS studies open to children and teens are recruiting participants at sites in Baltimore as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Baltimore at a glance

  • 9 studies are recruiting at a site in Baltimore.
  • By phase: Phase 3 (4), Phase 4 (3), No phase (2). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (5), industry (4).
  • By research area: ADHD (4), Epilepsy (2), Migraine (2), Depression (1).
  • Most recent update to one of these records: November 3, 2026.

ADHD studies recruiting in Baltimore

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    Kennedy Krieger Institute
    Registry record
    NCT04781140 · updated
  2. Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

    • Phase 4
    • Ages 8 to 12
    • All sexes
    Sponsor
    Donald Gilbert, MD, MS, FAAN, FAAP
    Study site
    Kennedy Krieger Institute
    Registry record
    NCT04421248 · updated
  3. Medication Treatment of ADHD in Pediatric Epilepsy

    • Phase 4
    • Ages 6 to 17
    • All sexes
    Sponsor
    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
    Study site
    Kennedy Krieger Institute
    Registry record
    NCT07594652 · updated
  4. Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

    • No phase
    • Ages 8 to 12
    • All sexes
    Sponsor
    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
    Study sites
    Hugo W. Moser Research Institute at Kennedy Krieger · Kennedy Krieger Institute
    Registry record
    NCT06810180 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Baltimore, MD on ClinicalTrials.gov.

Depression studies recruiting in Baltimore

  1. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Johns Hopkins University
    Registry record
    NCT07227454 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Baltimore, MD on ClinicalTrials.gov.

Epilepsy studies recruiting in Baltimore

  1. Ketogenic Diet for New-Onset Absence Epilepsy

    • Phase 3
    • Ages 3 to 12
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins Hospital
    Registry record
    NCT04274179 · updated
  2. Effects of Recorded Music on Clinical and EEG Seizure Activity

    • No phase
    • Ages 4 to 17
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    Johns Hopkins School of Medicine
    Registry record
    NCT05289934 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Baltimore, MD on ClinicalTrials.gov.

Migraine studies recruiting in Baltimore

  1. A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    H. Lundbeck A/S
    Study site
    University of Maryland School of Medicine
    Registry record
    NCT05164172 · updated
  2. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Pharmasite Research, Inc. /ID# 227908
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Baltimore, MD on ClinicalTrials.gov.

Ask about studies near Baltimore

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call